Led by international experts in cannabis scientific research and drug policy reform, this segment covers key elements shaping scientific and research efforts for the global cannabis industry. Special attention is given to cannabis genetics, international drug policy, and current research surrounding corona virus (COVID-19) related to cannabis.
HEADQUARTERS 5614 Connecticut Ave NW #331 Washington, DC 20015
info@newfrontierdata.com 844-420-D8TA (3882)
Media Inquiries: media@newfrontierdata.com
Copyright © 2014-2023
Frontier Financial Group, Inc.
All Rights Reserved.
Terms of Use and Privacy Policy
